VACOP-B vs VACOP-B plus high-dose sequential therapy (RDS) for aggressive non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Santini, G [1 ]
Olivieri, A [1 ]
Majolino, I [1 ]
Chisesi, T [1 ]
Salvagno, L [1 ]
Biglio, A [1 ]
de Souza, C [1 ]
Congiu, M [1 ]
Rizzoli, V [1 ]
机构：
[1] Osped San Martino Genova, Dept Haematol, Genoa, Italy
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3576
引用
收藏
页码：862A / 862A
页数：1
相关论文
共 50 条
  • [31] Flexi-VACOP/B followed by high-dose cytoxan (CY) and high dose therapy plus autologous peripheral blood progenitor cell (PBPC) rescue for aggressive NHL with bone marrow involvement at diagnosis
    Congiu, AM
    Coser, P
    Leoni, P
    Salvagno, L
    Santini, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 325 - 325
  • [32] High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: The Bologna experience
    Zinzani, PL
    Tani, M
    Gabriele, A
    Gherlinzoni, F
    De Vivo, A
    Ricci, P
    Bandini, G
    Lemoli, RM
    Motta, MR
    Rizzi, S
    Guidice, V
    Zompatori, M
    Stefoni, V
    Alinari, L
    Musuraca, G
    Marchi, E
    Bassi, S
    Conte, R
    Pileri, S
    Tura, S
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (02) : 321 - 326
  • [33] High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.
    Oyan, B
    Koc, Y
    Kansu, E
    BLOOD, 2002, 100 (11) : 471B - 471B
  • [34] Glofitamab in Aggressive B Non-Hodgkin Lymphoma (B-NHL): A Real World Experience
    Chan, Thomas
    Kwong, Yok Lam
    Tse, Eric
    BLOOD, 2023, 142
  • [35] High-dose sequential (RDS) chemotherapy with high-dose ARA-C and Rituximab prolongs the survival of patients with resistant/relapsed B-cell non-Hodgkin's lymphoma.
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Bellavita, P
    Motta, T
    Barbui, T
    BLOOD, 2002, 100 (11) : 646A - 646A
  • [36] High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma
    Verdonck, LF
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3003 - 3003
  • [37] High-dose therapy and stem cell transplantation (BMT) for relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Shahidi, H
    Gregory, SA
    GuptaBurt, S
    Adler, SS
    Venugopal, P
    Meyer, P
    Korenblit, AD
    Recine, D
    Manson, S
    Kaizer, H
    BLOOD, 1997, 90 (10) : 1023 - 1023
  • [38] High-dose ifosfamide and etoposide infusion plus methylprednisolone for refractory or relapsed aggressive non-Hodgkin's lymphoma
    Salar, A
    Martino, R
    Altés, A
    Sureda, A
    Brunet, S
    Sierra, J
    HAEMATOLOGICA, 2000, 85 (02) : 217 - 219
  • [39] High-Dose sequential (HDS) chemotherapy supplemented with rituximab: a feasible and effective first line approach for patients with aggressive and indolent Non-Hodgkin's Lymphoma (NHL)
    Ladetto, M
    Zallio, F
    Vallet, S
    Ricca, I
    Cuttica, A
    Caracciolo, D
    Corradini, P
    Astolfi, M
    Sametti, S
    Volpato, F
    Vitolo, U
    Gianni, AM
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2001, 27 : S262 - S262
  • [40] Rituximab does not improve survival of patients treated with M/VACOP-B plus radiotherapy in primary mediastinal large B-cell lymphoma (PMLBCL): An Italian phase II study of Intergruppo Italiano Linfomi (IIL)
    Martelli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 96 - 96
12345